1.Date of the board of directors resolution:2017/05/03

2.Source of capital increase funds:

 Issuance of new common shares for cash to sponsor the DR Offering

3.Number of shares issued:

 It will be proposed that the shareholders meeting to authorize the Board,

 within the limit of 165,000,000 common shares, depending on the market

 conditions and the Company’s capital needs, to choose appropriate timing

 and fund raising method(s), to issue new commons shares for cash to

 sponsor DR Offering and/or issue Private Placement Shares.

 Even though all planned common stock issuance through new commons shares

 for cash to sponsor DR Offering and/or Private Placement Shares are

 conducted, the total number of stocks only amounts 13.13% of capital after

 the increase in capital.

4.Par value per share:NT$10.

5.Total monetary amount of the issue:To be determined.

6.Issue price:To be determined.

7.Number of shares subscribed by or allotted to employees:

 10% of the new common shares shall be allocated for the employees'

 subscription.

8.Number of shares publicly sold:

 Except for 10% of the new common shares shall be allocated for the

 employees' subscription in accordance with the applicable law, rights to

 subscribe to the remaining shares shall be waived by the shareholders

 and such remaining shares should be offered to the public under

 Article 28-1 of the Securities and Exchange Law as the underlying

 shares of the global depositary shares to be sold in the DR Offering.

9.Ratio of shares subscribed by or allotted as stock dividends to existing

  shareholders:None.

10.Method of handling fractional shares and shares unsubscribed by the

   deadline:

  Any new common shares not subscribed by employees of the Company shall

  be determined by the Chairman, depending on the market needs, to be

  allocated as underlying shares of the global depositary shares or to

  be subscribed by the designated person(s).

11.Rights and obligations of the newly issued shares:

  The new common shares will have the same rights and obligations as the

  Company’s existing issued and outstanding common shares.

12.Utilization of the funds from the capital increase:

  The purchase of machine and equipment, repay bank loans, enrich working

  capital, have sound financial structure and/or support the company's

  long term development funding needs and plans.

13.Any other matters that need to be specified:

  It will be proposed that 2017 annual general shareholders' meeting to

  authorize the Board.